Yahoo Canada Web Search

Search results

  1. People also ask

  2. BRISBANE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced the pricing of an underwritten public offering of 7,142,858 shares of its Class A common stock at a price to the public of $42.00 ...

  3. 3 days ago · Vera Therapeutics files automatic mixed securities shelf Vera Therapeutics price target raised to $64 from $56 at Guggenheim Disney initiated, Cisco upgraded: Wall Street’s top analyst calls

  4. Find the latest Vera Therapeutics, Inc. (VERA) stock quote, history, news and other vital information to help you with your stock trading and investing.

  5. 3 days ago · Vera Therapeutics 7.14M share Secondary priced at $42.00. October 29, 2024 — 08:55 pm EDT. Written by TheFly for TipRanks ->. The deal priced below last closing price of $42.97. JPMorgan ...

  6. Get a real-time Vera Therapeutics, Inc. (VERA) stock price quote with breaking news, financials, statistics, charts and more.

    • 2.22
    • 107.85M
    • 2.26B
    • 54.83M
  7. Apr 5, 2024 · Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases.

  8. Get the latest Vera Therapeutics Inc (VERA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  1. People also search for